购物车
- 全部删除
- 您的购物车当前为空
Pelcitoclax (APG-1252) is a powerful inhibitor of the Bcl-2 and Bcl-xl proteins, displaying significant antineoplastic and pro-apoptotic properties[1].
Pelcitoclax (APG-1252) is a powerful inhibitor of the Bcl-2 and Bcl-xl proteins, displaying significant antineoplastic and pro-apoptotic properties[1].
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 18,600 | 8-10周 | |
10 mg | ¥ 29,300 | 8-10周 | |
25 mg | ¥ 44,200 | 8-10周 | |
50 mg | ¥ 57,100 | 8-10周 |
产品描述 | Pelcitoclax (APG-1252) is a powerful inhibitor of the Bcl-2 and Bcl-xl proteins, displaying significant antineoplastic and pro-apoptotic properties[1]. |
体外活性 | APG-1252 changes to the reactive metabolite named APG-1252-M1, which has remarkable antitumor effects in acute myeloid leukemia[1]. |
体内活性 | Pelcitoclax (APG-1252; 25-100 mg/kg; i.v.; once a day; for 10days) treatment inhibits xenograft tumor growth more obviously than the other groups[1]. |
分子量 | 1281.84 |
分子式 | C57H66ClF4N6O11PS4 |
CAS No. | 1619923-36-2 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容